HIV Pre-Exposure Prophylaxis (PrEP) purchase patterns and STI occurrence among Israeli men: A cohort analysis

BACKGROUND: HIV Pre-exposure prophylaxis (PrEP) is the regular use of antiretroviral medication by people who are not infected with HIV to prevent seroconversion. Israel approved PrEP for continuous use in 2017, and Israeli Health Maintenance Organizations (HMO) offered PrEP with a copayment to elig...

Descripción completa

Detalles Bibliográficos
Autores principales: Chemtob, Daniel, Weil, Clara, Hannink Attal, Jordan, Hawila, Elias, Noff Sadeh, Enav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601516/
https://www.ncbi.nlm.nih.gov/pubmed/34793473
http://dx.doi.org/10.1371/journal.pone.0259168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601516/
https://www.ncbi.nlm.nih.gov/pubmed/34793473
http://dx.doi.org/10.1371/journal.pone.0259168

Ejemplares similares